CTRI/2020/08/027246尚未招募未知
Role of Tocilizumab in Patients with Moderate to Severe COVID-19 Pneumonia
GCS Medical College Hospital and Research Centre0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •RT-PCR COVID-19 Test Positive patients will be included
- •Moderate to Severe COVID Pneumonia patients will be included
排除标准
- •Patients with Active Tuberculosis, Past history of Tuberculosis, Other active suspected Viral/Fungal infection, Platelet count <50,000/ml and Absolute Pneutrophil Count <1000/ml will be excluded
研究者
相似试验
尚未招募
3 期
The use of tocilizumab in patients with severe COVID 19 pneumonia - a trial to know its efficacy in those on steroidsCTRI/2020/12/029793aveen Naik B
尚未招募
3 期
Study on Tocilizumab in Patients with Predicted Severe Acute Pancreatitis (STOP-SAP) for Preventing Progression to Actual Severe Acute Pancreatitis: A Randomized, Double-Blind, Placebo-Controlled Trialpredicted severe acute pancreatitissevere acute pancreatitisTCTR20210302008Chulalongkorn University50
进行中（未招募）
3 期
Tocilizumab role in reducing the complications of COVID patientsPneumonia due to COVID-19B34.2RBR-25rtydqady Reading Hospital-MTI Peshawar
已完成
不适用
Efficacy and Safety of treatment with tocilizumab in refractory patients with Takayasu ArteritisTakayasu arteritisJPRN-UMIN000007845Department of Cardiovascular Medicine Graduate School of Medicine Osaka University15
已完成
不适用
The safety and efficacy of tocilizumab in patients with neuromyelitis optica: Multicenter Studyneuromyelitis opticaJPRN-UMIN000007866Department of Immunology, National Institute of Neuroscience, NCNP15